Cardiovascular Risk Factors in Children with Obesity, Preventive Diagnostics and Possible Interventions

Mirjam Močnik1, Nataša Marčun Varda1,2

  • 1Department of Paediatrics, University Medical Centre Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia.

Metabolites
|August 26, 2021
PubMed

Insights

Childhood obesity significantly increases cardiovascular risks, leading to early adulthood events. Early prevention and intervention strategies are crucial for mitigating these long-term health consequences.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Metabolic Disorders

Background:

  • Obesity is a growing global health concern with significant implications for cardiovascular health.
  • Childhood obesity contributes to hormonal changes and vascular dysfunction, increasing long-term cardiovascular risk.
  • Associated conditions include hypertension, hyperinsulinemia, chronic kidney disease, and dyslipidemia.

Purpose of the Study:

  • To review the cardiovascular complications associated with childhood obesity.
  • To outline the diagnostic workup for obesity-related cardiovascular issues in children.
  • To discuss preventive strategies and interventions for pediatric cardiovascular risk reduction.

Main Methods:

  • Comprehensive literature review on obesity and cardiovascular disease in children.
  • Analysis of diagnostic protocols for cardiovascular assessment in pediatric obesity.
  • Synthesis of current preventive and therapeutic approaches.

Main Results:

  • Childhood obesity is strongly linked to increased cardiovascular morbidity and mortality.
  • Obesity-induced hormonal and vascular changes predispose children to hypertension, dyslipidemia, and cardiac dysfunction.
  • Early identification and intervention are critical for preventing adult cardiovascular events.

Conclusions:

  • Childhood obesity poses a substantial threat to cardiovascular health, necessitating proactive management.
  • A multi-faceted approach involving early diagnosis and tailored interventions is essential.
  • Reducing the burden of childhood obesity is key to preventing future cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
521
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
411
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
741
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
30
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
30
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
532